Cargando…

Biochemical aspects of dementias

Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and...

Descripción completa

Detalles Bibliográficos
Autor principal: Hock, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181716/
https://www.ncbi.nlm.nih.gov/pubmed/22034215
_version_ 1782212796213100544
author Hock, Christoph
author_facet Hock, Christoph
author_sort Hock, Christoph
collection PubMed
description Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and social care, treatments designed to prevent or reverse these diseases are urgently needed. The most common major biochemical characteristic of these neurodegenerative diseases is the deposition of abnormal protein aggregates in brain. The decryption of the mechanisms of aggregation and associated neurotoxicity may reveal new therapeutic targets, which will enable treatment for these devastating conditions.
format Online
Article
Text
id pubmed-3181716
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31817162011-10-27 Biochemical aspects of dementias Hock, Christoph Dialogues Clin Neurosci Basic Research Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and social care, treatments designed to prevent or reverse these diseases are urgently needed. The most common major biochemical characteristic of these neurodegenerative diseases is the deposition of abnormal protein aggregates in brain. The decryption of the mechanisms of aggregation and associated neurotoxicity may reveal new therapeutic targets, which will enable treatment for these devastating conditions. Les Laboratoires Servier 2003-03 /pmc/articles/PMC3181716/ /pubmed/22034215 Text en Copyright: © 2003 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic Research
Hock, Christoph
Biochemical aspects of dementias
title Biochemical aspects of dementias
title_full Biochemical aspects of dementias
title_fullStr Biochemical aspects of dementias
title_full_unstemmed Biochemical aspects of dementias
title_short Biochemical aspects of dementias
title_sort biochemical aspects of dementias
topic Basic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181716/
https://www.ncbi.nlm.nih.gov/pubmed/22034215
work_keys_str_mv AT hockchristoph biochemicalaspectsofdementias